Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.44
+0.02 (0.19%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Arvinas Employees
Arvinas had 246 employees as of December 31, 2025. The number of employees decreased by 184 or -42.79% compared to the previous year.
Employees
246
Change (1Y)
-184
Growth (1Y)
-42.79%
Revenue / Employee
$1,067,480
Profits / Employee
-$328,455
Market Cap
667.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 246 | -184 | -42.79% |
| Dec 31, 2024 | 430 | -15 | -3.37% |
| Dec 31, 2023 | 445 | 30 | 7.23% |
| Dec 31, 2022 | 415 | 135 | 48.21% |
| Dec 31, 2021 | 280 | 101 | 56.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| ProKidney | 231 |
| Prime Medicine | 146 |
| Alpha Tau Medical | 121 |
| Adlai Nortye | 109 |
| BridgeBio Oncology Therapeutics | 92 |
| Forte Biosciences | 19 |
| Relmada Therapeutics | 17 |
ARVN News
- 5 weeks ago - Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson's Disease Treated for 28 Days - GlobeNewsWire
- 6 weeks ago - Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders - GlobeNewsWire
- 6 weeks ago - Arvinas Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Arvinas Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Arvinas Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Arvinas Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire